circRNA TCFL5 Promote Esophageal Cancer Progression by Modulating M2 Macrophage Polarization via the miR-543-FMNL2 Axis

Objective The mechanism of circRNA on M2 macrophage polarization, which contributes to esophageal cancer, remains unclear. This study is aimed at clarifying the mechanism of circRNA on esophageal cancer by regulating M2 macrophage polarization. Methods The expression of circRNA TCFL5 and miR-543 was detected by qRT-PCR. Western blot was used to detect the expression of FMNL2 and CD163. CCK-8 and transwell assay was used to detect the proliferation, migration, and invasion of Eca109 and KYSE150, respectively. Flow cytometry was used to detect the CD163 positive cells. The contents of IL-10, TGF-β, TNF-α, IL-6, and IL-1β were detected by ELISA. A dual-luciferase reporter system was used to detect the regulation of miR-543 to circRNA TCFL5 and FMNL2. Results 156 upregulated circRNAs and 91 downregulated circRNAs in esophageal cancer tissues were identified, and the expression of circRNA TCFL5 showed the most significant upregulation. Overexpression of circRNA TCFL5 promotes proliferation, invasion, and migration of Eca109 and KYSE150 and promotes tumor growth in vivo. circRNA TCFL5 served as a sponge of miR-543, and FMNL2 was a downstream target gene of miR-543. circRNA TCFL5 promotes cell proliferation, migration, and invasion of Eca109 and KYSE150 by modulating the miR-543/FMNL2 axis. Macrophage M2 polarization promoted proliferation, invasion, and migration of Eca109 and KYSE150 cells, and circRNA TCFL5 mediated macrophage M2 polarization by regulating the FMNL2/miR-543 axis. Conclusion In the present study, we identified that circRNA TCFL5 was dramatically upregulated in esophageal cancer, and circRNA TCFL5 promotes esophageal cancer progression by modulating M2 macrophage polarization via the miR-543-FMNL2 axis, which provides a potential target for the treatment of esophageal cancer.

[1]  B. Goh,et al.  The potential role of exosomal circRNAs in the tumor microenvironment: insights into cancer diagnosis and therapy , 2022, Theranostics.

[2]  Rong Li,et al.  miR-543 impairs cell proliferation, migration, and invasion in breast cancer by suppressing VCAN. , 2021, Biochemical and biophysical research communications.

[3]  Jianjun Jiang,et al.  Oesophageal squamous cell carcinoma–associated IL‐33 rewires macrophage polarization towards M2 via activating ornithine decarboxylase , 2020, Cell proliferation.

[4]  Ting Zhang,et al.  Tumor-Associated Macrophages in Tumor Immunity , 2020, Frontiers in Immunology.

[5]  W. Liang,et al.  Tumor-associated macrophage polarization promotes the progression of esophageal carcinoma , 2020, Aging.

[6]  Xiang Fei,et al.  Hypoxic Tumor-Derived Exosomal Circ0048117 Facilitates M2 Macrophage Polarization Acting as miR-140 Sponge in Esophageal Squamous Cell Carcinoma , 2020, OncoTargets and therapy.

[7]  D. Kwong,et al.  FOXO1 promotes tumor progression by increased M2 macrophage infiltration in esophageal squamous cell carcinoma , 2020, Theranostics.

[8]  Xuan Peng,et al.  Targeting tumor-associated macrophages in the tumor microenvironment , 2020, Oncology letters.

[9]  Dongwei Su,et al.  MiR-543 inhibits proliferation and metastasis of human colorectal cancer cells by targeting PLAS3. , 2020, European review for medical and pharmacological sciences.

[10]  Geng Xu,et al.  The treatments and postoperative complications of esophageal cancer: a review , 2020, Journal of Cardiothoracic Surgery.

[11]  K. Koike,et al.  Tumor microenvironment in gastric cancers , 2020, Cancer science.

[12]  Yijiang Chen,et al.  Circular RNA LPAR3 sponges microRNA‐198 to facilitate esophageal cancer migration, invasion, and metastasis , 2020, Cancer science.

[13]  Shi-ze Yang,et al.  circRNA_001275 upregulates Wnt7a expression by competitively sponging miR-370-3p to promote cisplatin resistance in esophageal cancer , 2020, International journal of oncology.

[14]  Yan Yan,et al.  CircHIPK3 promotes colorectal cancer cells proliferation and metastasis via modulating of miR-1207-5p/FMNL2 signal. , 2020, Biochemical and biophysical research communications.

[15]  Y. Li,et al.  MiR-543 functions as tumor suppressor in ovarian cancer by targeting TWIST1. , 2020, Journal of biological regulators and homeostatic agents.

[16]  D. Abraham,et al.  Cancer Immunotherapy: Targeting Tumor-Associated Macrophages by Gene Silencing. , 2020, Methods in molecular biology.

[17]  Minghui Wang,et al.  Hsa_circ_0006948 enhances cancer progression and epithelial-mesenchymal transition through the miR-490-3p/HMGA2 axis in esophageal squamous cell carcinoma , 2019, Aging.

[18]  Xin Wang,et al.  CircRNA_100367 regulated the radiation sensitivity of esophageal squamous cell carcinomas through miR-217/Wnt3 pathway , 2019, Aging.

[19]  Lei Zhao,et al.  Diagnostic Accuracy of circRNAs in Esophageal Cancer: A Meta-Analysis , 2019, Disease markers.

[20]  Jørgen Kjems,et al.  The biogenesis, biology and characterization of circular RNAs , 2019, Nature Reviews Genetics.

[21]  Yijun Guo,et al.  Identification and verification of differentially expressed microRNAs and their target genes for the diagnosis of esophageal cancer , 2018, Oncology Letters.

[22]  Sheng-Jie Yu,et al.  Esophageal cancer: Risk factors, genetic association, and treatment. , 2016, Asian journal of surgery.

[23]  Pari M. Shah,et al.  Screening and prevention strategies and endoscopic management of early esophageal cancer. , 2017, Chinese clinical oncology.

[24]  Yiping Yang,et al.  Tumor-associated macrophages: implications in cancer immunotherapy. , 2017, Immunotherapy.

[25]  He-da Zhang,et al.  CircRNA: a novel type of biomarker for cancer , 2017, Breast Cancer.

[26]  Handong Ma,et al.  MicroRNA-543 suppresses colorectal cancer growth and metastasis by targeting KRAS, MTA1 and HMGA2 , 2016, Oncotarget.

[27]  Li Yang,et al.  Regulation of circRNA biogenesis , 2015, RNA biology.

[28]  H. Kato,et al.  Treatments for esophageal cancer: a review , 2013, General Thoracic and Cardiovascular Surgery.

[29]  X. Bian,et al.  FMNL2 is a positive regulator of cell motility and metastasis in colorectal carcinoma , 2011, The Journal of pathology.